相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Markus W. Loeffler et al.
GENOME MEDICINE (2019)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
The perfect personalized cancer therapy: cancer vaccines against neoantigens
Luigi Aurisicchio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer
Andrew J. Rech et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
Yugang Guo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao et al.
NATURE GENETICS (2018)
Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
Annacarmen Petrizzo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma
E. Ghorani et al.
ANNALS OF ONCOLOGY (2018)
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
Maria Parkhurst et al.
CLINICAL CANCER RESEARCH (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Luksza et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
Chan-Young Ock et al.
NATURE COMMUNICATIONS (2017)
High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma
A. Miller et al.
BLOOD CANCER JOURNAL (2017)
Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multiomics analysis of glioblastoma multiforme
Lin Feng et al.
SCIENTIFIC REPORTS (2017)
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
Sivan Seliktar-Ofir et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
Terhi Karpanen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Targeting neoantigens to augment antitumour immunity (vol 17, pg 209, 2017)
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
The genomic landscape of breast cancer and its interaction with host immunity
Stephen Luen et al.
BREAST (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma
Hirokazu Matsushita et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer
Noura J. Choudhury et al.
EUROPEAN UROLOGY FOCUS (2016)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
Darin A. Wick et al.
CLINICAL CANCER RESEARCH (2014)
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Yong-Chen Lu et al.
CLINICAL CANCER RESEARCH (2014)
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
Fei Duan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HLA-Binding Properties of Tumor Neoepitopes in Humans
Edward F. Fritsch et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
Exploring the Genomes of Cancer Cells: Progress and Promise
Michael R. Stratton
SCIENCE (2011)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
